Department of Speech and Hearing Sciences, University College Cork, Ireland.
Department of Logopedics, University of Oulu, Finland.
Lang Speech Hear Serv Sch. 2021 Apr 20;52(2):738-754. doi: 10.1044/2020_LSHSS-20-00058. Epub 2021 Jan 19.
Purpose The aim of this study was to examine the degree to which quantitative aspects of dosage (dose, dose frequency, and total intervention duration) have been examined in intervention studies for children with developmental language disorder (DLD). Additionally, to establish the optimal quantitative dosage characteristics for phonology, vocabulary, and morphosyntax outcomes. Method This registered review (PROSPERO ID CRD42017076663) adhered to PRISMA guidelines. Search terms were included in seven electronic databases. We included peer-reviewed quasi-experimental, randomized controlled trial or cohort analytical studies, published in any language between January 2006 and May 2020. Included articles reported on participants with DLD ( = 3-18 years); oral language interventions with phonology, vocabulary, or morphosyntax outcomes; and experimental manipulation or statistical analysis of any quantitative aspect of dosage. Studies were appraised using the Cochrane risk-of-bias tool. Results Two hundred forty-four articles reported on oral language interventions with children with DLD in the domains of interest; 13 focused on experimentally/statistically manipulating quantitative aspects of dosage. No article reported phonological outcomes, three reported vocabulary, and eight reported morphosyntax. Dose frequency was the most common characteristic manipulated. Conclusions Research is in its infancy, and significant further research is required to inform speech-language pathologists in practice. Dosage characteristics are rarely adequately controlled for their individual effects to be identified. Findings to date suggest that there is a point in vocabulary and morphosyntax interventions after which there are diminishing returns from additional dosage. If dose is high (number of learning opportunities within a session), then the literature suggests that session frequency can be reduced. Frequent, short sessions (2/3 × per week, approximately 2 min) and less frequent, long sessions (1 × per week, approximately 20 min) have yielded the best outcomes when composite language measures have been used; however, replication and further research are required before clinicians can confidently integrate these findings into clinical practice. Supplemental Material https://doi.org/10.23641/asha.13570934.
目的 本研究旨在考察针对语言发育迟缓(DLD)儿童的干预研究中,定量方面(剂量、剂量频率和总干预持续时间)的检查程度。此外,还确定了语音、词汇和形态句法结果的最佳定量剂量特征。 方法 本注册综述(PROSPERO ID CRD42017076663)遵循 PRISMA 指南。搜索词包含在七个电子数据库中。我们纳入了同行评审的准实验、随机对照试验或队列分析研究,发表于 2006 年 1 月至 2020 年 5 月期间的任何语言。纳入的文章报告了患有 DLD(3-18 岁)的参与者;具有语音、词汇或形态句法结果的口头语言干预;以及剂量的任何定量方面的实验操作或统计分析。使用 Cochrane 偏倚风险工具评估研究。 结果 244 篇文章报道了 DLD 儿童在感兴趣领域的口头语言干预;13 篇文章专注于实验/统计上操纵剂量的定量方面。没有文章报告语音结果,有 3 篇报告词汇,有 8 篇报告形态句法。剂量频率是最常见的操纵特征。 结论 研究仍处于起步阶段,需要进一步开展大量研究,为实践中的言语语言病理学家提供信息。剂量特征很少得到充分控制,无法确定其单独的效果。迄今为止的研究结果表明,在词汇和形态句法干预中,存在一个剂量增加回报递减的点。如果剂量高(一个疗程内的学习机会数量),那么文献表明可以降低疗程频率。使用综合语言测量时,短而频繁的疗程(每周 2/3 次,大约 2 分钟)和长而不频繁的疗程(每周 1 次,大约 20 分钟)取得了最好的结果;然而,在临床医生能够有信心地将这些发现纳入临床实践之前,需要进行复制和进一步的研究。 补充材料 https://doi.org/10.23641/asha.13570934.